Literature DB >> 25574052

Automatic identification of reticular pseudodrusen using multimodal retinal image analysis.

Mark J J P van Grinsven1, Gabriëlle H S Buitendijk2, Corina Brussee2, Bram van Ginneken1, Carel B Hoyng3, Thomas Theelen3, Caroline C W Klaver2, Clara I Sánchez1.   

Abstract

PURPOSE: To examine human performance and agreement on reticular pseudodrusen (RPD) detection and quantification by using single- and multimodality grading protocols and to describe and evaluate a machine learning system for the automatic detection and quantification of reticular pseudodrusen by using single- and multimodality information.
METHODS: Color fundus, fundus autofluoresence, and near-infrared images of 278 eyes from 230 patients with or without presence of RPD were used in this study. All eyes were scored for presence of RPD during single- and multimodality setups by two experienced observers and a developed machine learning system. Furthermore, automatic quantification of RPD area was performed by the proposed system and compared with human delineations.
RESULTS: Observers obtained a higher performance and better interobserver agreement for RPD detection with multimodality grading, achieving areas under the receiver operating characteristic (ROC) curve of 0.940 and 0.958, and a κ agreement of 0.911. The proposed automatic system achieved an area under the ROC of 0.941 with a multimodality setup. Automatic RPD quantification resulted in an intraclass correlation (ICC) value of 0.704, which was comparable with ICC values obtained between single-modality manual delineations.
CONCLUSIONS: Observer performance and agreement for RPD identification improved significantly by using a multimodality grading approach. The developed automatic system showed similar performance as observers, and automatic RPD area quantification was in concordance with manual delineations. The proposed automatic system allows for a fast and accurate identification and quantification of RPD, opening the way for efficient quantitative imaging biomarkers in large data set analysis. Copyright 2015 The Association for Research in Vision and Ophthalmology, Inc.

Entities:  

Keywords:  age-related macular degeneration; automatic detection; reticular pseudodrusen

Mesh:

Year:  2015        PMID: 25574052     DOI: 10.1167/iovs.14-15019

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  10 in total

1.  Fundus autofluorescence and optical coherence tomography biomarkers associated with the progression of geographic atrophy secondary to age-related macular degeneration.

Authors:  Patricia T A Bui; Gregor S Reiter; Maria Fabianska; Sebastian M Waldstein; Christoph Grechenig; Hrvoje Bogunovic; Mustafa Arikan; Ursula Schmidt-Erfurth
Journal:  Eye (Lond)       Date:  2021-08-16       Impact factor: 4.456

2.  Reticular Pseudodrusen: The Third Macular Risk Feature for Progression to Late Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report 30.

Authors:  Elvira Agrón; Amitha Domalpally; Catherine A Cukras; Traci E Clemons; Qingyu Chen; Zhiyong Lu; Emily Y Chew; Tiarnan D L Keenan
Journal:  Ophthalmology       Date:  2022-05-31       Impact factor: 14.277

Review 3.  Subretinal drusenoid deposits: An update.

Authors:  Manuel Monge; Adriana Araya; Lihteh Wu
Journal:  Taiwan J Ophthalmol       Date:  2022-05-26

Review 4.  Artificial intelligence for improving sickle cell retinopathy diagnosis and management.

Authors:  Sophie Cai; Ian C Han; Adrienne W Scott
Journal:  Eye (Lond)       Date:  2021-05-06       Impact factor: 4.456

5.  Automated Retinal Image Analysis for Evaluation of Focal Hyperpigmentary Changes in Intermediate Age-Related Macular Degeneration.

Authors:  Steffen Schmitz-Valckenberg; Arno P Göbel; Stefan C Saur; Julia S Steinberg; Sarah Thiele; Christian Wojek; Christoph Russmann; Frank G Holz
Journal:  Transl Vis Sci Technol       Date:  2016-03-04       Impact factor: 3.283

6.  Age-related macular degeneration in a randomized controlled trial of low-dose aspirin: Rationale and study design of the ASPREE-AMD study.

Authors:  Liubov Robman; Robyn Guymer; Robyn Woods; Stephanie Ward; Rory Wolfe; James Phung; Lauren Hodgson; Galina Makeyeva; Khin Zaw Aung; Tom Gilbert; Jessica Lockery; Y-Anh Le-Pham; Suzanne Orchard; Elsdon Storey; Walter Abhayaratna; Daniel Reid; Michael E Ernst; Mark Nelson; Christopher Reid; John McNeil
Journal:  Contemp Clin Trials Commun       Date:  2017-03-27

7.  Subretinal Drusenoid Deposits and Photoreceptor Loss Detecting Global and Local Progression of Geographic Atrophy by SD-OCT Imaging.

Authors:  Gregor S Reiter; Reinhard Told; Markus Schranz; Lukas Baumann; Georgios Mylonas; Stefan Sacu; Andreas Pollreisz; Ursula Schmidt-Erfurth
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-06-03       Impact factor: 4.799

8.  Clinical study protocol for a low-interventional study in intermediate age-related macular degeneration developing novel clinical endpoints for interventional clinical trials with a regulatory and patient access intention-MACUSTAR.

Authors:  Jan H Terheyden; Frank G Holz; Steffen Schmitz-Valckenberg; Anna Lüning; Matthias Schmid; Gary S Rubin; Hannah Dunbar; Adnan Tufail; David P Crabb; Alison Binns; Clara I Sánchez; Carel Hoyng; Philippe Margaron; Nadia Zakaria; Mary Durbin; Ulrich Luhmann; Parisa Zamiri; José Cunha-Vaz; Cecília Martinho; Sergio Leal; Robert P Finger
Journal:  Trials       Date:  2020-07-18       Impact factor: 2.279

9.  Age-related changes of the retinal microvasculature.

Authors:  Nikita V Orlov; Cristopher Coletta; Freekje van Asten; Yong Qian; Jun Ding; Majd AlGhatrif; Edward Lakatta; Emily Chew; Wai Wong; Anand Swaroop; Edoardo Fiorillo; Alessandro Delitala; Michele Marongiu; Ilya G Goldberg; David Schlessinger
Journal:  PLoS One       Date:  2019-05-02       Impact factor: 3.240

10.  Intraretinal Correlates of Reticular Pseudodrusen Revealed by Autofluorescence and En Face OCT.

Authors:  Maarjaliis Paavo; Winston Lee; John Merriam; Srilaxmi Bearelly; Stephen Tsang; Stanley Chang; Janet R Sparrow
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-09-01       Impact factor: 4.799

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.